Teladoc Health Inc Receivables Turnover Ratio (TDOC), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Teladoc Health Inc   (NYSE: TDOC)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

Teladoc Health Inc Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Teladoc Health Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 11.94, above the company average. This is a clear sign of healthy business climate in the Healthcare Facilities industry and improving liquidity at their respective customers, during the first quarter 2026. Average collection period, for Teladoc Health Inc 's accounts receivable remained unchanged at 31 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 16 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 267, from overall ranking in the fourth quarter 2025 at 1091.

What is Receivable Turnover Ratio?
What is Teladoc Health Inc Selling?


What is Receivable Turnover Ratio?





TDOC Receivables Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Receivable Change -8.3 % -9.96 % -0.6 % 3.21 % 8.72 %
Y / Y Revenue Change -2.47 % 0.28 % -2.2 % -1.64 % -2.59 %
Receivable Turnover Ratio (TTM) 11.94 11.74 11.45 11.5 11.64
TDOC's Total Ranking # 267 # 1091 # 948 # 357 # 939
Accounts Receivable average collection period days 31 31 32 32 31
Seq. Receivable Change 10.79 % -8.51 % -6.51 % -3.24 % 8.79 %
Seq. Revenue Change -4.43 % 2.53 % -0.86 % 0.4 % -1.74 %


Receivable Turnover Company Ranking
Within: No.
Healthcare Facilities Industry # 7
Healthcare Sector # 17
Overall Market # 267

Receivable Turnover Ratio Statistics
High Average Low
0.88 0.43 0.03
(Mar 31 2026)  




  News about Teladoc Health Inc Receivables Turnover Ratios

Teladoc Health’s Dual Journey Innovative Amazon Partnership Amid Financial Headwinds,

Navigating Opportunities and Challenges: Teladoc Health on Amazon and Financial Frontiers In a significant development that underscores the synergies between digital healthcare and retail innovation, Teladoc Health has announced its integration with Amazon s Health Benefits Connector. This strategic collaboration enables eligible customers to seamlessly find and enroll in Teladoc Health’s cardiometabolic programs directly through Amazon’s platform. As healthcare continues its rapid digital transformation, such partnerships highlight the increasing importance of accessibility and consumer-centered healthcare services.Teladoc’s integration with Amazon signifies a leap forward in making specialized health programs more approachable for the broader public. Cardiometabolic programs, critical for managing diabetes, heart disease, and other metabolic syndromes, are crucial interventions in the current healthcare landscape. By leveraging Amazon s vast reach and trusted consumer interface, Teladoc aims to simplify enrollment processes and increase user participation rates in these vital health programs. Despite this promising advancement, Teladoc Health faces certain financial challenges that have surfaced in their recent quarterly performance reviews. According to the latest financial results ending September 30, 2024, Teladoc Health’s ability to collect accounts receivable has sequentially worsened to 12.01. While this marks a more challenging environment compared to the second quarter of 2024, experts suggest that this metric remains within a manageable range, avoiding any immediate concerns over financial instability.




Financial Statements
Teladoc Health Inc 's Accounts Receivable $ 214 Millions Visit TDOC's Balance sheet
Teladoc Health Inc 's Sales TTM $ 2,514 Millions Visit TDOC's Income Statement
Sources of TDOC's Revenues Visit TDOC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TDOC's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TDOC's Growth Rates TDOC's Roa TDOC's Inventory Turnover Ratio TDOC's Dividend Comparisons
TDOC's Profitability Ratios TDOC's Roi TDOC's Asset Turnover Ratio TDOC's Dividend Growth
TDOC's Valuation Ratios TDOC's Roe TDOC's Financial Strength Ratios TDOC's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Receivable at quarter ending Mar 31 2026
U S Physical Therapy Inc  30.94 $ 795.488  Millions$ 25.708  Millions
Innovage Holding Corp   30.93 $ 949.172  Millions$ 30.688  Millions
Invo Fertility Inc   29.40 $ 7.219  Millions$ 0.246  Millions
Lineage Cell Therapeutics Inc   28.42 $ 14.779  Millions$ 0.520  Millions
Meiragtx Holdings Plc  28.01 $ 79.758  Millions$ 2.848  Millions
Cv Sciences Inc   27.37 $ 11.925  Millions$ 0.436  Millions
Wave Life Sciences Ltd   27.36 $ 88.173  Millions$ 3.223  Millions
Safe Pro Group Inc   27.29 $ 1.642  Millions$ 0.060  Millions
Atara Biotherapeutics Inc   27.03 $ 23.540  Millions$ 0.871  Millions
Biorestorative Therapies Inc   25.41 $ 0.363  Millions$ 0.014  Millions
Jaguar Health Inc   24.65 $ 29.569  Millions$ 1.200  Millions
Kiniksa Pharmaceuticals International Plc  24.63 $ 754.045  Millions$ 30.618  Millions
Polomar Health Services, Inc.  24.47 $ 1.649  Millions$ 0.067  Millions
Agenus Inc  24.33 $ 123.866  Millions$ 5.091  Millions
Igc Pharma Inc   23.44 $ 1.166  Millions$ 0.050  Millions
Cytomx Therapeutics Inc   23.09 $ 35.542  Millions$ 1.539  Millions
Siga Technologies Inc  22.41 $ 93.777  Millions$ 4.186  Millions
Lipocine Inc   22.09 $ 2.002  Millions$ 0.091  Millions
Ataibeckley Inc   21.56 $ 3.488  Millions$ 0.162  Millions
Fonar Corporation  21.15 $ 105.338  Millions$ 4.981  Millions
Neuraxis Inc   20.94 $ 4.282  Millions$ 0.204  Millions
Vystar Corporation  20.58 $ 0.048  Millions$ 0.002  Millions
Lifemd Inc   19.91 $ 177.869  Millions$ 8.934  Millions
Longeveron Inc   19.07 $ 1.216  Millions$ 0.064  Millions
Sonida Senior Living Inc   18.82 $ 411.850  Millions$ 21.878  Millions
Voyager Therapeutics Inc   17.99 $ 36.494  Millions$ 2.029  Millions
Nutriband Inc   16.79 $ 1.803  Millions$ 0.107  Millions
Bioadaptives Inc   16.64 $ 0.024  Millions$ 0.001  Millions
Premier Air Charter Holdings Inc   16.33 $ 33.205  Millions$ 2.033  Millions
Bioage Labs Inc   15.90 $ 10.316  Millions$ 0.649  Millions

Date modified: 2026-08-29T17:31:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.